Genetic Technologies Limited (GENE)
USD 0.77
(0.0%)
USD 0.77
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 643.54 Thousand AUD | 64.25% |
| 2023 | 532.84 Thousand AUD | -18.34% |
| 2022 | 652.52 Thousand AUD | 219.81% |
| 2021 | 204.03 Thousand AUD | -57.65% |
| 2020 | 481.78 Thousand AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 25 Thousand AUD | -99.0% |
| 2014 | 2.5 Million AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 17.74 Thousand AUD | -73.85% |
| 2011 | 67.87 Thousand AUD | -82.26% |
| 2010 | 382.64 Thousand AUD | -17.31% |
| 2009 | 462.72 Thousand AUD | 54.84% |
| 2008 | 298.83 Thousand AUD | -75.61% |
| 2007 | 1.22 Million AUD | -27.18% |
| 2006 | 1.68 Million AUD | 140.6% |
| 2005 | 699.35 Thousand AUD | 0.48% |
| 2004 | 696.04 Thousand AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | -100.0% |
| 2001 | 120.08 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 382.31 Thousand AUD | 0.0% |
| 2024 Q1 | 84.13 Thousand AUD | -84.21% |
| 2024 FY | 875.18 Thousand AUD | 64.25% |
| 2024 Q4 | 643.54 Thousand AUD | 0.0% |
| 2024 Q3 | 643.54 Thousand AUD | 68.33% |
| 2023 Q3 | 229.27 Thousand USD | -62.56% |
| 2023 Q4 | 532.84 Thousand AUD | 132.4% |
| 2023 FY | 532.84 Thousand AUD | -18.34% |
| 2023 Q1 | 328.41 Thousand USD | -49.67% |
| 2023 Q2 | 612.39 Thousand AUD | 86.47% |
| 2022 FY | 652.52 Thousand AUD | 219.81% |
| 2022 Q2 | 113.48 Thousand AUD | 238.66% |
| 2022 Q3 | 388.39 Thousand AUD | 242.24% |
| 2022 Q4 | 652.52 Thousand AUD | 68.01% |
| 2022 Q1 | 33.51 Thousand AUD | -83.58% |
| 2021 Q3 | 24.41 Thousand AUD | -93.35% |
| 2021 Q1 | 116.43 Thousand AUD | -75.83% |
| 2021 Q2 | 366.99 Thousand AUD | 215.2% |
| 2021 FY | 204.03 Thousand AUD | -57.65% |
| 2021 Q4 | 204.03 Thousand AUD | 735.81% |
| 2020 FY | 481.78 Thousand AUD | 0.0% |
| 2020 Q1 | 137.3 Thousand AUD | 0.0% |
| 2020 Q2 | 362.08 Thousand AUD | 163.71% |
| 2020 Q3 | 240.87 Thousand AUD | -33.48% |
| 2020 Q4 | 481.78 Thousand AUD | 100.02% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q3 | - AUD | 0.0% |
| 2018 Q1 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q3 | 25 Thousand AUD | -98.33% |
| 2015 FY | 25 Thousand AUD | -99.0% |
| 2015 Q2 | 1.5 Million AUD | 0.0% |
| 2015 Q4 | 25 Thousand AUD | 0.0% |
| 2015 Q1 | 1.5 Million AUD | -40.06% |
| 2014 Q3 | 2.5 Million AUD | -53.25% |
| 2014 FY | 2.5 Million AUD | 0.0% |
| 2014 Q2 | 5.35 Million AUD | 0.0% |
| 2014 Q1 | 5.35 Million AUD | 0.0% |
| 2014 Q4 | 2.5 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 Q2 | 43.4 Thousand AUD | 0.0% |
| 2012 FY | 17.74 Thousand AUD | -73.85% |
| 2012 Q4 | 17.74 Thousand AUD | 0.0% |
| 2011 Q4 | 67.87 Thousand AUD | 0.0% |
| 2011 FY | 67.87 Thousand AUD | -82.26% |
| 2011 Q2 | 262.64 Thousand AUD | 0.0% |
| 2010 Q4 | 382.64 Thousand AUD | 0.0% |
| 2010 FY | 382.64 Thousand AUD | -17.31% |
| 2010 Q2 | 497.43 Thousand AUD | 0.0% |
| 2009 Q4 | 373.44 Thousand AUD | 0.0% |
| 2009 FY | 462.72 Thousand AUD | 54.84% |
| 2009 Q2 | 446.45 Thousand AUD | 0.0% |
| 2008 FY | 298.83 Thousand AUD | -75.61% |
| 2008 Q4 | 298.83 Thousand AUD | 0.0% |
| 2008 Q2 | 233.22 Thousand AUD | 0.0% |
| 2007 Q4 | 1.22 Million AUD | 0.0% |
| 2007 FY | 1.22 Million AUD | -27.18% |
| 2007 Q2 | 779.91 Thousand AUD | 0.0% |
| 2006 Q4 | 1.68 Million AUD | 0.0% |
| 2006 Q2 | - AUD | 0.0% |
| 2006 FY | 1.68 Million AUD | 140.6% |
| 2005 Q4 | 699.35 Thousand AUD | 0.0% |
| 2005 FY | 699.35 Thousand AUD | 0.48% |
| 2005 Q2 | 700.22 Thousand AUD | 0.0% |
| 2004 FY | 696.04 Thousand AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2002 FY | - AUD | -100.0% |
| 2001 FY | 120.08 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -51.067% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | 48.007% |
| Aspira Women's Health Inc. | 2.26 Million USD | 71.6% |
| Biodesix, Inc. | 60.69 Million USD | 98.94% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -382.436% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | 59.234% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | 59.234% |
| Bionano Genomics, Inc. | 87.94 Million USD | 99.268% |
| CareDx, Inc | 34.22 Million USD | 98.119% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 15.31 Million USD | 95.797% |
| DarioHealth Corp. | 29.54 Million USD | 97.822% |
| Exact Sciences Corporation | 2.55 Billion USD | 99.975% |
| Fulgent Genetics, Inc. | 14.9 Million USD | 95.683% |
| Guardant Health, Inc. | 1.35 Billion USD | 99.952% |
| ICON Public Limited Company | 3.93 Billion USD | 99.984% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 99.932% |
| Illumina, Inc. | 2.26 Billion USD | 99.972% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | 26.151% |
| iSpecimen Inc. | 196.24 Thousand USD | -227.932% |
| Standard BioTools Inc. | 98.21 Million USD | 99.345% |
| MDxHealth SA | 41.26 Million USD | 98.44% |
| 23andMe Holding Co. | 76.51 Million USD | 99.159% |
| Medpace Holdings, Inc. | 142.12 Million USD | 99.547% |
| Myriad Genetics, Inc. | 145 Million USD | 99.556% |
| Mainz Biomed B.V. | 7.42 Million USD | 91.328% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -63.17% |
| NeoGenomics, Inc. | 611.67 Million USD | 99.895% |
| Neogen Corporation | 906.23 Million USD | 99.929% |
| Inotiv, Inc. | 417.64 Million USD | 99.846% |
| Natera, Inc. | 441.99 Million USD | 99.854% |
| OPKO Health, Inc. | 326.56 Million USD | 99.803% |
| Psychemedics Corporation | 2.29 Million USD | 71.995% |
| Prenetics Global Limited | 2.36 Million USD | 72.839% |
| Prenetics Global Limited | 2.36 Million USD | 72.839% |
| Precipio, Inc. | 1.11 Million USD | 42.335% |
| Personalis, Inc. | 48.96 Million USD | 98.686% |
| RadNet, Inc. | 1.49 Billion USD | 99.957% |
| Sera Prognostics, Inc. | 1.85 Million USD | 65.364% |
| Sotera Health Company | 2.32 Billion USD | 99.972% |
| Neuronetics, Inc. | 62.47 Million USD | 98.97% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 82.168% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 82.168% |
| Trinity Biotech plc | 67.42 Million USD | 99.046% |
| Twist Bioscience Corporation | 94.06 Million USD | 99.316% |
| Exagen Inc. | 23.72 Million USD | 97.287% |